Filing Details
- Accession Number:
- 0000315066-22-001561
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-14 17:13:02
- Reporting Period:
- 2022-04-12
- Accepted Time:
- 2022-04-14 17:13:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1745999 | Beam Therapeutics Inc. | BEAM | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-04-12 | 978,503 | $0.00 | 2,935,511 | No | 4 | J | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Common Stock | Acquisiton | 2022-04-12 | 509,490 | $0.00 | 509,995 | No | 4 | J | Indirect | Impresa Fund III Limited Partnership |
| Common Stock | Disposition | 2022-04-12 | 509,332 | $0.00 | 663 | No | 4 | J | Indirect | Impresa Fund III Limited Partnership |
| Common Stock | Acquisiton | 2022-04-12 | 137,845 | $0.00 | 141,151 | No | 4 | J | Indirect | F-Prime Capital Partners Healthcare Advisors Fund V LP |
| Common Stock | Disposition | 2022-04-12 | 128,333 | $0.00 | 12,818 | No | 4 | J | Indirect | F-Prime Capital Partners Healthcare Advisors Fund V LP |
| Common Stock | Acquisiton | 2022-04-12 | 15,406 | $0.00 | 18,803 | No | 4 | J | Indirect | F-Prime Inc. |
| Common Stock | Acquisiton | 2022-04-12 | 422,120 | $0.00 | 2,490,515 | No | 4 | J | Indirect | Shares held by persons and entities whose shares are subject to reporting by the undersigned. |
| Common Stock | Disposition | 2022-04-13 | 663 | $50.75 | 0 | No | 4 | S | Indirect | Impresa Fund III Limited Partnership |
| Common Stock | Disposition | 2022-04-13 | 6,799 | $50.70 | 12,004 | No | 4 | S | Indirect | F-Prime Inc. |
| Common Stock | Disposition | 2022-04-13 | 8,804 | $50.01 | 3,200 | No | 4 | S | Indirect | F-Prime Inc. |
| Common Stock | Disposition | 2022-04-13 | 3,200 | $50.80 | 0 | No | 4 | S | Indirect | F-Prime Inc. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| No | 4 | J | Indirect | Impresa Fund III Limited Partnership |
| No | 4 | J | Indirect | Impresa Fund III Limited Partnership |
| No | 4 | J | Indirect | F-Prime Capital Partners Healthcare Advisors Fund V LP |
| No | 4 | J | Indirect | F-Prime Capital Partners Healthcare Advisors Fund V LP |
| No | 4 | J | Indirect | F-Prime Inc. |
| No | 4 | J | Indirect | Shares held by persons and entities whose shares are subject to reporting by the undersigned. |
| No | 4 | S | Indirect | Impresa Fund III Limited Partnership |
| No | 4 | S | Indirect | F-Prime Inc. |
| No | 4 | S | Indirect | F-Prime Inc. |
| No | 4 | S | Indirect | F-Prime Inc. |
Footnotes
- These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.50 to $51.00. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $49.75 to $50.50. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
